Bringing Unlicensed Medicinal Cannabis To UK Patients

Executive Summary

Therismos has enabled Wellford, a leading medicinal cannabis company, to import and distribute unlicensed controlled drugs in the UK. With its comprehensive range of licences and unlicensed product operational expertise, Therismos ensured that patients could access much-needed treatments that were not available through traditional channels.

Introduction

As the medicinal cannabis market began to take shape in the UK, Wellford needed the capability to navigate the complex regulatory landscape surrounding the distribution of unlicensed controlled drugs. Therismos, with its extensive licensing and operational services, was the ideal choice to bring Wellford’s products to market efficiently and compliantly.

Challenges/Problems

• Regulatory Complexity: the distribution of unlicensed medicinal cannabis is subject to strict regulations, including the need for controlled drug licences.
• Market Access: without the right licences and infrastructure, Wellford would have struggled to get their products to UK patients.
• Lack of Operational Infrastructure: building an in-house distribution function would have been both time-consuming and costly.

Solution

Therismos provided a turnkey operational solution, leveraging its Wholesale Dealer Authorisation, controlled drugs licence and capability to import and release unlicensed medicines to procure and distribute Wellford’s products. This has allowed Wellford to focus on growing its market presence while Therismos handled all logistical and regulatory challenges.

Implementation

Therismos managed the entire supply chain, from procuring the unlicensed products to distributing them within the UK. Our team ensured full compliance with the UK’s stringent regulations for the supply of medicinal cannabis, mitigating risk for Wellford while ensuring patients had timely access to the products they needed.

Results/Outcomes

• Successful Market Entry: Wellford’s products reached the UK market without delays, enabling immediate patient access.
• Regulatory Compliance: Therismos ensured full compliance with UK laws governing unlicensed and controlled drugs.
• Freedom to Focus on Marketing: Wellford was able to concentrate fully on driving market growth.

Key Takeaways

This case study demonstrates Therismos’ ability to handle the complexities of distributing unlicensed medicinal cannabis in the UK. By partnering with us, Wellford was able to meet patient needs while remaining compliant with all regulatory requirements.